Merck Profit Guidance: Adjusted Earnings Forecast Lowered
Merck profit guidance took a notable hit on Thursday, as the pharmaceutical giant revised its full-year earnings expectations downward, reflecting an estimated $200 million in costs associated with tariffs and a recent licensing charge.The revised outlook sets Merck’s adjusted earnings for 2025 between $8.82 and $8.97 per share, a dip from its previous forecast of $8.88 to $9.03 per share.
Merck Profit Guidance: Adjusted Earnings Forecast Lowered Read More »